AdvisorShares Vice ETF (ACT) financial statements (2020 and earlier)

Company profile

Business Address MORRIS CORPORATE CENTER III
PARSIPPANY, NJ 07054
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2013
TTM
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 328
Cash and cash equivalents 319
Short-term investments 9
Receivables 1,303
Inventory, net of allowances, customer advances and progress billings1,543
Inventory 1,543
Prepaid expense and other current assets404
Other undisclosed current assets 302
Total current assets: 3,880
Noncurrent Assets
Property, plant and equipment 1,480
Long-term investments and receivables 10
Long-term investments 10
Intangible assets, net (including goodwill)8,592
Goodwill 4,762
Intangible assets, net (excluding goodwill) 3,830
Prepaid expense and other noncurrent assets81
Other undisclosed noncurrent assets 62
Total noncurrent assets: 10,224
TOTAL ASSETS: 14,104
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 2,429
Employee-related liabilities 260
Taxes payable 68
Other undisclosed accounts payable and accrued liabilities 2,100
Debt 176
Deferred revenue and credits 32
Deferred tax liabilities 5
Other undisclosed current liabilities 68
Total current liabilities: 2,711
Noncurrent Liabilities
Long-term debt and lease obligation 6,257
Long-term debt, excluding current maturities 6,257
Liabilities, other than long-term debt 1,237
Deferred revenue and credits 11
Pension and other postretirement defined benefit plans, liabilities 20
Accrued income taxes 8
Deferred tax liabilities, net 1,035
Other liabilities 163
Other undisclosed noncurrent liabilities 42
Total noncurrent liabilities: 7,537
Total liabilities: 10,247
Stockholders' equity
Stockholders' equity attributable to parent 3,834
Common stock 0
Treasury stock, value (343)
Additional paid in capital 1,957
Accumulated other comprehensive income 37
Retained earnings 2,183
Stockholders' equity attributable to noncontrolling interest 23
Total stockholders' equity: 3,856
TOTAL LIABILITIES AND EQUITY: 14,104

Income statement (P&L) ($ in millions)

9/30/2013
TTM
12/31/2012
Revenues 5,915
Revenue, net 5,915
Cost of revenue (3,997)
Cost of goods and services sold (3,493)
Gross profit: 1,918
Operating expenses (1,597)
Operating income: 321
Nonoperating expense (76)
Other nonoperating income 39
Interest and debt expense (117)
Income from continuing operations before equity method investments, income taxes: 128
Income from equity method investments 1
Other undisclosed income from continuing operations before income taxes 115
Income from continuing operations before income taxes: 245
Income tax expense (147)
Net income: 98
Net loss attributable to noncontrolling interest (1)
Net income available to common stockholders, diluted: 97

Comprehensive Income ($ in millions)

9/30/2013
TTM
12/31/2012
Net income: 98
Other comprehensive income 113
Comprehensive income: 212
Comprehensive income, net of tax, attributable to noncontrolling interest 1
Other undisclosed comprehensive loss, net of tax, attributable to parent (2)
Comprehensive income, net of tax, attributable to parent: 211

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: